October 2014, Vol 4, No 6

Arzerra (Ofatumumab) Receives FDA Approval for Patients with Previously Untreated Chronic Lymphocytic Leukemia for Use in Combination with Chlorambucil

By Lisa A. Raedler, PhD, RPh

Drug Updates

FDA-Approved Medications Used for the Treatment of Breast Cancer

Breast Cancer, ICD Codes

October 2014, Vol 4, No 6

Connecting Patients to Resources

By Sheryl A. Riley, RN, OCN, CMCN

Reimbursement

October 2014, Vol 4, No 6

Changes in our economy and healthcare system (ie, the Affordable Care Act, accountable care organizations, evolving reimbursement models) have given birth to a new member of the healthcare team: the financial advocate. Read More ›

CMS Takes Stock of Federal Health Insurance Marketplace Benefits

By Rosemary Frei, MSc

Practice Management

October 2014, Vol 4, No 6

FDA to Regulate Laboratory-Developed Tests

By Rosemary Frei, MSc

October 2014, Vol 4, No 6

Do’s and Don’ts in Physician–Hospital Alignment, Part 2

By Max Reiboldt, CPA

Practice Management

October 2014, Vol 4, No 6

Community–Hospital Relationships: Working Together to Define What Is Right for Patients

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

October 2014, Vol 4, No 6

Disaster Planning for the Oncology Office, Part 2

By Mariana S-B Lamb, MS

Practice Management

October 2014, Vol 4, No 6